MiR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Jan 19

PMID 28099468

Citations 17

Authors

Xia Shan

Wei Wen

Danxia Zhu

Ting Yan

Wenfang Cheng

Zebo Huang

Lan Zhang

Huo Zhang

Tongshan Wang

Wei Zhu

Yichao Zhu

Jun Zhu

Affiliations

Soon will be listed here.

Abstract

The metastasis of gastric cancer, one of the most common tumors, has a molecular mechanism that is still largely unclear. Here we investigated the role of possible tumor-suppressor miR-1296-5p in the cell migration and invasion of ERBB2-positive gastric cancer. It found that miR-1296-5p was significantly down-regulated in gastric cancer tissues. Moreover, it was down-regulated in lymph node metastatic gastric cancer tissues compared with non-metastatic gastric cancer tissues. The luciferase activity of ERBB2 3'-untranslated region-based reporters constructed in SNU-216 and NUGC-4 gastric cancer cells suggested that ERBB2 was the target gene of miR-1296-5p. Overexpressed miR-1296-5p reduced its target protein level and Rac1 activation, and inhibited the migration and invasion of SNU-216 and NUGC-4 gastric cancer cells. MiR-1296-5p was down-regulated in ERBB2-positive gastric cancer tissues compared with ERBB2-negative gastric cancer tissues. In ERBB2-positive gastric cancers, the miR-1296-5p expression was suppressed in a majority of metastatic lymph node tissues compared to non-metastatic gastric cancer samples. The migration and invasion of gastric cancer cells was inhibited by miR-1296-5p overexpression or herceptin treatment, and rescued by the overexpression of constitutively active Rac1-Q61L or ERBB2. Taken together, our findings first suggest that miR-1296-5p might be involved in the regulation on the migration and invasion of human gastric cancer cells at least in part via targeting ERBB2/Rac1 signaling pathway.

Citing Articles

The effect of bta-miR-1296 on the proliferation and extracellular matrix synthesis of bovine mammary fibroblasts.

Yang Y, Yuan T, Wu R, Geng Z, Lian S, Wang J In Vitro Cell Dev Biol Anim. 2024; 60(2):183-194.

PMID: 38409638 DOI: 10.1007/s11626-024-00851-0.

Identification of Circulating Exosomal microRNAs Associated with Radioiodine Refractory in Papillary Thyroid Carcinoma.

Li G, Chen W, Gong Y, Wei T, Gong R, Zhu J J Pers Med. 2022; 12(12).

PMID: 36556238 PMC: 9788488. DOI: 10.3390/jpm12122017.

A Review on Nanocarrier Mediated Treatment and Management of Triple Negative Breast Cancer: A Saudi Arabian Scenario.

Nahvi I, Belkahla S, Biswas S, Chakraborty S Front Oncol. 2022; 12:953865.

PMID: 35941873 PMC: 9356294. DOI: 10.3389/fonc.2022.953865.

Improved delivery of miR-1296 loaded cationic nanoliposomes for effective suppression of triple negative breast cancer.

Albakr L, Alqahtani F, Aleanizy F, Alomrani A, Badran M, Alhindas H Saudi Pharm J. 2021; 29(5):446-455.

PMID: 34135670 PMC: 8180610. DOI: 10.1016/j.jsps.2021.04.007.

Long Non-Coding RNA Cancer Susceptibility 9 (CASC9) Up-Regulates the Expression of ERBB2 by Inhibiting miR-193a-5p in Colorectal Cancer.

Ding Y, Li X, Zhang Y, Zhang J Cancer Manag Res. 2020; 12:1281-1292.

PMID: 32110102 PMC: 7039100. DOI: 10.2147/CMAR.S234620.

References

Boo L, Ho W, Ali N, Yeap S, Ky H, Chan K . MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line. Int J Biol Sci. 2016; 12(4):427-45. PMC: 4807162. DOI: 10.7150/ijbs.12777. View

Majid S, Dar A, Saini S, Chen Y, Shahryari V, Liu J . Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Res. 2010; 70(7):2809-18. DOI: 10.1158/0008-5472.CAN-09-4176. View

Zurleni T, Gjoni E, Ballabio A, Casieri R, Ceriani P, Marzoli L . Sixth and seventh tumor-node-metastasis staging system compared in gastric cancer patients. World J Gastrointest Surg. 2014; 5(11):287-93. PMC: 3920116. DOI: 10.4240/wjgs.v5.i11.287. View

Zhu Y, Shen T, Liu J, Zheng J, Zhang Y, Xu R . Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells. Cell Signal. 2013; 25(5):1075-85. DOI: 10.1016/j.cellsig.2013.01.015. View

Liu J, Zhang Y, Xu R, Du J, Hu Z, Yang L . PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration. Cell Signal. 2012; 25(2):447-56. DOI: 10.1016/j.cellsig.2012.10.012. View

Hartgrink H, Jansen E, van Grieken N, van de Velde C . Gastric cancer. Lancet. 2009; 374(9688):477-90. PMC: 4613761. DOI: 10.1016/S0140-6736(09)60617-6. View

Zhao D, Chen Y, Jiang H, Lu J, Zhang G, Geng J . Serum miR-210 and miR-30a expressions tend to revert to fetal levels in Chinese adult patients with chronic heart failure. Cardiovasc Pathol. 2013; 22(6):444-50. DOI: 10.1016/j.carpath.2013.04.001. View

Phan B, Majid S, Ursu S, de Semir D, Nosrati M, Bezrookove V . Tumor suppressor role of microRNA-1296 in triple-negative breast cancer. Oncotarget. 2016; 7(15):19519-30. PMC: 4991398. DOI: 10.18632/oncotarget.6961. View

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

10.

Bourguignon L, Gilad E, Peyrollier K . Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration. J Biol Chem. 2007; 282(27):19426-41. DOI: 10.1074/jbc.M610054200. View

11.

Wang S, Shin I, Wu F, Friedman D, Arteaga C . HER2/Neu (ErbB2) signaling to Rac1-Pak1 is temporally and spatially modulated by transforming growth factor beta. Cancer Res. 2006; 66(19):9591-600. DOI: 10.1158/0008-5472.CAN-06-2071. View

12.

Fabi A, Mottolese M, Segatto O . Therapeutic targeting of ERBB2 in breast cancer: understanding resistance in the laboratory and combating it in the clinic. J Mol Med (Berl). 2014; 92(7):681-95. DOI: 10.1007/s00109-014-1169-7. View

13.

Ishimoto T, Baba H, Izumi D, Sugihara H, Kurashige J, Iwatsuki M . Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation. Int J Cancer. 2015; 138(6):1337-49. DOI: 10.1002/ijc.29627. View

14.

Dong Z, Fu S, Xu X, Yang Y, Du L, Li W . Leptin-mediated regulation of ICAM-1 is Rho/ROCK dependent and enhances gastric cancer cell migration. Br J Cancer. 2014; 110(7):1801-10. PMC: 3974087. DOI: 10.1038/bjc.2014.70. View

15.

Johnson E, Seachrist D, DeLeon-Rodriguez C, Lozada K, Miedler J, Abdul-Karim F . HER2/ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42. J Biol Chem. 2010; 285(38):29491-501. PMC: 2937981. DOI: 10.1074/jbc.M110.136770. View

16.

Verbeek B, Vroom T, Beckers T, Rijksen G . Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts. FEBS Lett. 1998; 425(1):145-50. DOI: 10.1016/s0014-5793(98)00224-5. View

17.

Weissinger F, Reymond M, Dumke K, Kruger M . Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T). Onkologie. 2011; 34(10):548-51. DOI: 10.1159/000332226. View

18.

Yu D, Hung M . Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene. 2001; 19(53):6115-21. DOI: 10.1038/sj.onc.1203972. View

19.

Tornillo G, Bisaro B, Camacho-Leal M, Galie M, Provero P, Di Stefano P . p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1. Eur J Cell Biol. 2010; 90(2-3):237-48. DOI: 10.1016/j.ejcb.2010.09.002. View

20.

Liu Z, He W, Gao J, Luo J, Huang X, Gao C . Computational prediction and experimental validation of a novel synthesized pan-PIM inhibitor PI003 and its apoptosis-inducing mechanisms in cervical cancer. Oncotarget. 2015; 6(10):8019-35. PMC: 4480732. DOI: 10.18632/oncotarget.3139. View